» Articles » PMID: 20565935

Self-reported History of Pap-smear in HIV-positive Women in Northern Italy: a Cross-sectional Study

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2010 Jun 23
PMID 20565935
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The incidence of invasive cervical cancer in HIV-positive women is higher than in the general population. There is evidence that HIV-positive women do not participate sufficiently in cervical cancer screening in Italy, where cervical cancer is more than 10-fold higher in women with AIDS than in the general population. The aim of the present study was to evaluate the history of Pap-smear in HIV-positive women in Italy in recent years. We also examined the sociodemographic, clinical, and organizational factors associated with adherence to cervical cancer screening.

Methods: A cross-sectional study was conducted between July 2006 and June 2007 in Emilia-Romagna region (Northern Italy). All HIV-positive women who received a follow-up visit in one of the 10 regional infectivology units were invited to participate. History of Pap-smear, including abnormal smears and subsequent treatment, was investigated through a self-administered anonymous questionnaire. The association between lack of Pap-smear in the year preceding the interview and selected characteristics was assessed by means of odds ratios (OR) and 95% confidence intervals adjusted for study centre and age.

Results: A total of 1,002 HIV-positive women were interviewed. Nine percent reported no history of Pap-smear, and 39% had no Pap-smear in the year prior to the date of questionnaire (last year). The lack of Pap-smear in the last year was significantly associated with age <35 years (OR = 1.4, compared to age > or =45 years), lower education level (OR = 1.3), first HIV-positive test in the last 2 years (OR = 1.4), and CD4 count <200 cells/microl (OR = 1.6). Conversely, when women were advised by a gynecologist rather than other health workers to undergo screening, it significantly increased adherence. Non-significantly higher proportions of lack of Pap-smear in the last year were found in women born in Central-Eastern Europe (OR = 1.8) and Africa (OR = 1.3). No difference in history of Pap-smear emerged by mode of HIV-acquisition or AIDS status.Three hundred five (34%) women reported a previous abnormal Pap-smear, and of the 178 (58%) referred for treatment, 97% complied.

Conclusions: In recent years the self-reported history of Pap-smear in HIV-positive women, in some public clinics in Italy, is higher than previously reported, but further efforts are required to make sure cervical cancer screening is accessible to all HIV-positive women.

Citing Articles

Awareness, attendance, and attitudes toward cervical cancer screening among HIV-positive Chinese women in Yunnan province: a cross-sectional study.

Hu J, Duan R, Zhang H, Zhao X, Wu A, Li L BMC Womens Health. 2024; 24(1):636.

PMID: 39633302 PMC: 11616238. DOI: 10.1186/s12905-024-03478-1.


Cervical cancer screening utilization and associated factors among women living with HIV in Ethiopia, 2024: systematic review and meta-analysis.

Yirsaw A, Nigusie A, Andualem F, Getachew E, Getachew D, Tareke A BMC Womens Health. 2024; 24(1):521.

PMID: 39300442 PMC: 11411767. DOI: 10.1186/s12905-024-03362-y.


Prevalence and risk factors associated with precancerous and cancerous cervical lesions among HIV-infected women in University of Gondar specialized comprehensive referral hospital, Northwest Ethiopia: cross-sectional study design.

Worku E, Yigizaw G, Admassu R, Mekonnen D, Gessessa W, Tessema Z BMC Womens Health. 2024; 24(1):322.

PMID: 38834999 PMC: 11149268. DOI: 10.1186/s12905-024-03174-0.


Prevalence and trends of cervical cancer screening among women in Fiji from 2014 to 2018.

Kunatoga A, Mohammadnezhad M, Khan S, Naeem P, Nusair P Heliyon. 2024; 10(9):e30220.

PMID: 38707371 PMC: 11068636. DOI: 10.1016/j.heliyon.2024.e30220.


Prevalence and predictors of cervical cancer screening among HIV-positive women in rural western Uganda: insights from the health-belief model.

Vigneshwaran E, Goruntla N, Bommireddy B, Mantargi M, Mopuri B, Thammisetty D BMC Cancer. 2023; 23(1):1216.

PMID: 38066496 PMC: 10709934. DOI: 10.1186/s12885-023-11683-8.


References
1.
Stein M, Cunningham W, Nakazono T, Turner B, Andersen R, Bozzette S . Screening for cervical cancer in HIV-infected women receiving care in the United States. J Acquir Immune Defic Syndr. 2001; 27(5):463-6. DOI: 10.1097/00126334-200108150-00007. View

2.
Oster A, Sullivan P, Blair J . Prevalence of cervical cancer screening of HIV-infected women in the United States. J Acquir Immune Defic Syndr. 2009; 51(4):430-6. DOI: 10.1097/QAI.0b013e3181acb64a. View

3.
. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum. 2008; 90:1-636. PMC: 4781057. View

4.
Grulich A, van Leeuwen M, Falster M, Vajdic C . Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007; 370(9581):59-67. DOI: 10.1016/S0140-6736(07)61050-2. View

5.
Franceschi S, Dal Maso L, Suligoi B, Rezza G . Evidence for lack of cervical cancer screening among HIV-positive women in Italy. Eur J Cancer Prev. 2006; 15(6):554-6. DOI: 10.1097/01.cej.0000220640.69341.59. View